View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Rafael Bonardell
  • Rafael Bonardell

AMADEUS: 3Q’25 RESULTS (ANÁLISIS BANCO SABADELL)

3Q'25 vs. 3Q'24 Results Sales: € 1.635 Bn (+5.6% vs. +5.0% BS(e) and +4.7% consensus); EBITDA: € 652.7 M (+8.2% vs. +5.1% BS(e) and +4.9% consensus); 9M'25 vs. 9M'24 Results Sales: € 4.895 Bn (+6.4% vs. +6.2% BS(e) and +6.1% consensus); EBITDA: € 1.929 Bn (+6.8% vs. +5.8% BS(e) and +5.7% consensus);

Rafael Bonardell
  • Rafael Bonardell

IAG: 3Q’25 RESULTS (ANÁLISIS BANCO SABADELL)

3Q'25 vs. 3Q'24 Results Sales: € 9.328 Bn (0.0% vs. +2.3% BS(e) and n/a consensus); EBIT: € 2.053 Bn (+2.0% vs. +12.8% BS(e) and +4.1% consensus); 9M'25 vs. 9M'24 Results Sales: € 25.234 Bn (+4.9% vs. +5.8% BS(e) and n/a consensus); EBIT: € 5.852 Bn (+76.2% vs. +24.9% BS(e) and +19.6% consensus);

Luis Arredondo
  • Luis Arredondo

SACYR: 3Q’25 RESULTS (ANÁLISIS BANCO SABADELL)

3Q'25 vs. 3Q'24 Results Sales: € 1.175 Bn (2.8% vs. 3.1% BS(e) and 1.3% consensus); EBITDA: € 371 M (27.7% vs. 23.0% BS(e) and 20.1% consensus); EBIT: € 273 M (1.2% vs. 15.2% BS(e) and 20.2% consensus); Net Profit: € 31 M (41.5% vs. 35.1% BS(e) and 70.7% consensus). 9M'25 vs. 9M'24 Results Sales: € 3.412 Bn (4.6% vs. 4.7% BS(e) and 4.0% consensus); EBITDA: € 1.018 Bn (7.4% vs. 6.0% BS(e) and 5.1% consensus); EBIT: € 737 M (-15.2% vs. -10.9% BS(e) and -9.3% consensus); Net Profit: € 62 M (-16.2%...

Rafael Bonardell
  • Rafael Bonardell

IAG: RDOS. 3T’25 (ANÁLISIS BANCO SABADELL)

Rdos. 3T'25 vs 3T'24: Ventas: 9.328 M euros (0,0% vs +2,3% BS(e) y n/a consenso); EBIT: 2.053 M euros (+2,0% vs +12,8% BS(e) y +4,1% consenso). Rdos. 9meses'25 vs 9meses'24: Ventas: 25.234 M euros (+4,9% vs +5,8% BS(e) y n/a consenso); EBIT: 5.852 M euros (+76,2% vs +24,9% BS(e) y +19,6% consenso).

Andres Bolumburu
  • Andres Bolumburu

CELLNEX: 3Q’25 RESULTS (ANÁLISIS BANCO SABADELL)

3Q'25 vs. 3Q'24 Results Sales: € 995.0 M (+1.3% vs. +1.2% BS(e) and +1.3% consensus); EBITDA: € 831.0 M (+2.7% vs. +2.2% BS(e) and +2.2% consensus); Net Profit: € -158.0 M (vs. € 278 M in 3Q’24); 9M'25 vs. 9M'24 Results Sales: € 2.937 Bn (+1.2% vs. +1.1% BS(e) and +1.2% consensus); EBITDA: € 2.436 Bn (+2.1% vs. +1.9% BS(e) and +1.9% consensus); Net Profit: € -263.0 M (€ -148.0 M in 9M'24 vs);

Rafael Bonardell
  • Rafael Bonardell

AMADEUS: RDOS. 3T’25 (ANÁLISIS BANCO SABADELL)

Rdos. 3T'25 vs 3T'24: Ventas: 1.635 M euros (+5,6% vs +5,0% BS(e) y +4,7% consenso); EBITDA: 652,7 M euros (+8,2% vs +5,1% BS(e) y +4,9% consenso). Rdos. 9meses'25 vs 9meses'24: Ventas: 4.895 M euros (+6,4% vs +6,2% BS(e) y +6,1% consenso); EBITDA: 1.929 M euros (+6,8% vs +5,8% BS(e) y +5,7% consenso).

Andres Bolumburu
  • Andres Bolumburu

CELLNEX: RDOS. 9MESES’25 (ANÁLISIS BANCO SABADELL)

Rdos. 3T'25 vs 3T'24: Ventas: 995,0 M euros (+1,3% vs +1,2% BS(e) y +1,3% consenso); EBITDA: 831,0 M euros (+2,7% vs +2,2% BS(e) y +2,2% consenso); BDI: -158,0 M euros (vs 278 M euros en 3T’24); Rdos. 9meses'25 vs 9meses'24: Ventas: 2.937 M euros (+1,2% vs +1,1% BS(e) y +1,2% consenso); EBITDA: 2.436 M euros (+2,1% vs +1,9% BS(e) y +1,9% consenso); BDI: -263,0 M euros (-148,0 M euros en 9meses'24).

Luis Arredondo
  • Luis Arredondo

SACYR: RDOS. 3T’25 (ANÁLISIS BANCO SABADELL)

Rdos. 3T'25 vs 3T'24: Ventas: 1.175 M euros (2,8% vs 3,1% BS(e) y 1,3% consenso); EBITDA: 371 M euros (27,7% vs 23,0% BS(e) y 20,1% consenso); EBIT: 273 M euros (1,2% vs 15,2% BS(e) y 20,2% consenso); BDI: 31 M euros (41,5% vs 35,1% BS(e) y 70,7% consenso). Rdos. 9M'25 vs 9M'24: Ventas: 3.412 M euros (4,6% vs 4,7% BS(e) y 4,0% consenso); EBITDA: 1.018 M euros (7,4% vs 6,0% BS(e) y 5,1% consenso); EBIT: 737 M euros (-15,2% vs -10,9% BS(e) y -9,3% consenso); BDI: 62 M euros (-16,2% vs -18,2% BS...

Research Department
  • Research Department

IBERIAN DAILY 07 NOVEMBER + 3Q'25 RESULTS. HIGHLIGHTS AND REST OF PREV...

NEWS SUMMARY: ACS, AMADEUS, CELLNEX, IAG, SACYR. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 3Q’25 results to be released over the coming days in Spain. Doubts persist With the results campaign entering the final stretch, the main European indices closed with losses, with the IBEX standing out as the best performer, remaining at around 16,100. In the STOXX 600, Basic Mate...

Research Department
  • Research Department

INFORME DIARIO 07 NOVIEMBRE + RDOS. ESPAÑA Y EUROPA 3T’25. IDEAS DESTA...

COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ACS, AMADEUS, CELLNEX, IAG, SACYR. EUROPA: BAYER. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 3T’25 que se publicarán en España y Europa en los próximos días. Se mantienen las dudas Con la campaña de resultados entrando en su recta final, los principales índices europeos cerraron con pérdidas, destacando...

Research Department
  • Research Department

BANCO SABADELL RECOMMENDED PORTFOLIO WEEK 29 OCTOBER TO 05 NOVEMBER 20...

European Portfolio No changes this week. European High Yield Portfolio Air Liquide, Airbus, ASML, AXA & L’Oréal No changes this week. Spanish Recommended Portfolio No changes this week. 5-Stock Recommended Portfolio Cellnex, Ferrovial, IAG, Indra & Merlin No changes this week. 5 High-Yield Stock Portfolio Acerinox, Colonial, Iberdrola, Redeia and Santander We replace Mapfre with Santander. Mid&Small Recommended Portfolio Acerinox, Amper, CAF, CIE Automotive, Fluidra, Global Dominion, In...

Luis Arredondo
  • Luis Arredondo

ACS: RDOS. 3T'25 HOCHTIEF LIGERAMENTE POR ENCIMA, ELEVA GUIDANCE'25 DE...

Hochtief (~80% ACS) acaba de publicar unos Rdos.3T’25 ligeramente por encima en ventas (+9% vs 3T’24 vs +6,7% consenso) y en BDI operativo (183 M euros vs 176 M euros consenso; +23% vs 3T’24).

Research Department
  • Research Department

SEMANAL MERCADOS: BAJAMOS A NEUTRAL EN MEDIA Y SUBIMOS QUÍMICA (ANÁLIS...

Media es el peor sector del año (-16,5% vs +12,4% STOXX 600) ante la irrupción de la IA y las dificultades que plantearía para la monetización de sus servicios. También tendría sensibilidad negativa a actividad y al euro/dólar (negativo actualmente). Aunque cotiza a múltiplos atractivos, podría seguir lastrado por la IA y bajamos recomendación a Neutral. Química también acumula mala evolución este año (-6%) y estaría en niveles estresados en evolución relativa al STOXX 600 (

Research Department
  • Research Department

CAMBIO DE CARTERAS BANCO SABADELL SEMANA 29 OCTUBRE AL 05 NOVIEMBRE 20...

Cartera Modelo Europa Sin cambios esta semana. Cartera High Yield Europa Air Liquide, Airbus, ASML, AXA y L’Oréal Sin cambios esta semana. Cartera Modelo España Sale Mapfre y subimos peso en Iberdrola, Repsol, Sacyr, Colonial e Inditex. Cartera 5 Valores España Cellnex, Ferrovial, IAG, Indra y Merlin Sin cambios esta semana. Cartera 5 valores High Yield España Acerinox, Colonial, Iberdrola, Redeia y Santander Sale Mapfre y entra Santander. Cartera Pequeñas y Medianas España Acerinox, A...

Oscar Rodriguez
  • Oscar Rodriguez

ARCELOR MITTAL: 3Q’25 RESULTS AND T.P. INCREASE (ANÁLISIS BANCO SABADE...

3Q'25 vs. 3Q'24: EBITDA: US$ 1.508 Bn (-4.6% vs. -6.6% BS(e) and -7.4% consensus); Net Profit: US$ 474 M (-2.9% vs. -14.3% BS(e) and -17.2% consensus).

Luis Arredondo
  • Luis Arredondo

ROVI: 3Q’25 RESULTS (ANÁLISIS BANCO SABADELL)

3Q'25 vs. 3Q'24 Results Sales: € 210.51 M (-10.5% vs. -11.3% BS(e) and -11.0% consensus); EBITDA: € 83.9 M (-13.8% vs. -19.2% BS(e) and -15.0% consensus); EBIT: € 76.35 M (-15.3% vs. -21.0% BS(e) and -16.2% consensus); Net Profit: € 58.0 M (-16.1% vs. -18.5% BS(e) and -15.1% consensus); 9M'25 vs. 9M'24 Results Sales: € 525.1 M (-7.0% vs. -7.3% BS(e) and -7.2% consensus); EBITDA: € 149.5 M (-10.6% vs. -13.8% BS(e) and -11.3% consensus); EBIT: € 127.3 M (-13.2% vs. -16.7% BS(e) and -13.7% consensu...

Ignacio Romero
  • Ignacio Romero

LOGISTA: FY2025 RESULTS (ANÁLISIS BANCO SABADELL)

4Q'25 vs. 4Q'24 Results Sales: € 448.0 M (+2.1% vs. +1.7% BS(e) and +1.1% consensus); EBIT: € 91.0 M (-4.2% vs. -4.3% BS(e)); Net Profit: € 67.0 M (-5.6% vs. -9.3% BS(e)); FY2025 vs. FY2024 Results Sales: € 1.81 Bn (+3.0% vs. +2.9% BS(e) and +2.7% consensus); EBIT: € 378.0 M (-1.8% vs. -1.8% BS(e)); Net Profit: € 281.0 M (-8.8% vs. -9.6% BS(e));

Luis Arredondo
  • Luis Arredondo

FCC: RDOS. 3T’25 (ANÁLISIS BANCO SABADELL)

Rdos. 3T'25 vs 3T'24: Ventas: 2.494 M euros (+7,8% vs +5,3% BS(e)); EBITDA: 383,3 M euros (+1,6% vs +6,0% BS(e)); Rdos. 9meses'25 vs 9meses'24: Ventas: 7.051 M euros (+7,6% vs +6,7% BS(e)); EBITDA: 1.059 M euros (+7,4% vs +9,1% BS(e)).

Oscar Rodriguez
  • Oscar Rodriguez

ARCELORMITTAL: RDOS. 3T’25 Y CAMBIO DE P.O. AL ALZA (ANÁLISIS BANCO SA...

Rdos. 3T'25 vs 3T'24: EBITDA: 1.508 M euros (-4,6% vs -6,6% BS(e) y -7,4% consenso); BDI: 474 M euros (-2,9% vs -14,3% BS(e) y -17,2% consenso).

Arancha Pineiro
  • Arancha Pineiro

DHL GROUP: RDOS. 3T’25 (ANÁLISIS BANCO SABADELL)

Rdos. 3T'25 vs 3T'24: Ventas: 20.128 M euros (-2,3% vs -2,8% BS(e) y -2,6% consenso); EBIT: 1.477 M euros (+7,6% vs -7,6% BS(e) y -6,7% consenso); BDI: 840,0 M euros (+11,9% vs -5,9% BS(e) y -4,7% consenso). Rdos. 9meses'25 vs 9meses'24: Ventas: 60.763 M euros (-1,2% vs -1,4% BS(e) y -1,3% consenso); EBIT: 4.276 M euros (+5,9% vs +0,7% BS(e) y +1,0% consenso); BDI: 2.441 M euros (+9,1% vs +3,1% BS(e) y +3,5% consenso).

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch